AIM
XASE
$0.25
AIM ImmunoTech Inc. (AIM)
AIM ImmunoTech Inc., an immunpharmaceutical company, focuses on research and development of therapies to treat multiple types of cancers, viruses, and immunodeficiency disorders in the United States. The company is headquartered in Ocala, Florida.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $5.25 (+2000.00%)
Market Cap
$12M
PEG Ratio
0.71
Free Cash Flow Yield
-99.54%
Beta (5Y)
0.55
Price Chart
Valuation
Market Cap$12M
Forward P/E2.01
PEG0.71
P/S112.05
P/B4.82
Profitability
Total Revenue (TTM)$94K
Gross Profit (TTM)-$28K
EBITDA-$12M
Operating Margin-10118%
EPS-$4.96
Financial Health
Debt-to-Equity215.2%
Free Cash Flow Yield-99.54%
Growth & Risk
EPS 5Y CAGR-15.42%
Revenue 5Y CAGR-8.43%
FCF 5Y CAGR+1.66%
Beta (5Y)0.55
Sharpe Ratio-0.79